ISPC vs NVS
iSpecimen Inc (ISPC) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
NVS (NVS) common stock.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
NVS does not have a complete income-statement cache yet.
ISPC currently screens at market cap $4.4M. NVS currently screens at market cap $0.
Not investment advice. Open the ISPC and NVS stock pages for the full models.
Not investment advice.